MX2007008764A - Metodos para tratar capsulitis adhesiva. - Google Patents

Metodos para tratar capsulitis adhesiva.

Info

Publication number
MX2007008764A
MX2007008764A MX2007008764A MX2007008764A MX2007008764A MX 2007008764 A MX2007008764 A MX 2007008764A MX 2007008764 A MX2007008764 A MX 2007008764A MX 2007008764 A MX2007008764 A MX 2007008764A MX 2007008764 A MX2007008764 A MX 2007008764A
Authority
MX
Mexico
Prior art keywords
adhesive capsulitis
methods
collagenase
relates
shoulder
Prior art date
Application number
MX2007008764A
Other languages
English (en)
Inventor
Marie Badalamente
Original Assignee
Advance Biofactures Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Corp filed Critical Advance Biofactures Corp
Publication of MX2007008764A publication Critical patent/MX2007008764A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24007—Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

La invencion se refiere al descubrimiento de que las inyecciones de colagenasa son eficaces para lisar las uniones de colageno en la capsula del hombro y tratar el trastorno, capsulitis adhesiva. Como tal, la invencion se refiere a metodos para tratar o prevenir la capsulitis adhesiva u hombro congelado en un sujeto en necesidad de dicho tratamiento que comprende inyectar o suministrar de otra manera una cantidad eficaz de colagenasa a las uniones de colageno en el hombro. La invencion tambien se refiere al uso de colagenasa en la fabricacion de un medicamento para tratar capsulitis adhesiva.
MX2007008764A 2005-01-21 2006-01-19 Metodos para tratar capsulitis adhesiva. MX2007008764A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64577205P 2005-01-21 2005-01-21
US67744005P 2005-05-03 2005-05-03
US71947005P 2005-09-22 2005-09-22
PCT/US2006/001980 WO2006078870A2 (en) 2005-01-21 2006-01-19 Methods for treating adhesive capsulitis

Publications (1)

Publication Number Publication Date
MX2007008764A true MX2007008764A (es) 2007-10-19

Family

ID=36692898

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007008764A MX2007008764A (es) 2005-01-21 2006-01-19 Metodos para tratar capsulitis adhesiva.

Country Status (22)

Country Link
US (5) US20060204488A1 (es)
EP (2) EP1846022B1 (es)
JP (1) JP4967081B2 (es)
KR (2) KR100989267B1 (es)
CN (1) CN101107006B (es)
AU (1) AU2006206393B2 (es)
BR (1) BRPI0607280A2 (es)
CA (1) CA2593038C (es)
CY (1) CY1120193T1 (es)
DK (1) DK1846022T3 (es)
ES (1) ES2548516T3 (es)
HK (3) HK1109592A1 (es)
HR (1) HRP20150889T1 (es)
HU (1) HUE027236T2 (es)
ME (1) ME02344B (es)
MX (1) MX2007008764A (es)
NZ (1) NZ556160A (es)
PL (1) PL1846022T3 (es)
PT (1) PT1846022E (es)
RS (1) RS54265B1 (es)
SI (1) SI1846022T1 (es)
WO (1) WO2006078870A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
PL2274422T3 (pl) * 2008-04-17 2017-09-29 Anaeropharma Science, Inc. Wektor ekspresyjny
WO2012056044A1 (en) * 2010-10-30 2012-05-03 Imperial Innovations Ltd Treatment for dupuytren's disease
WO2013034416A1 (en) 2011-09-09 2013-03-14 Unilever N.V. Antimicrobial method and composition
EP2802652B1 (en) 2012-01-12 2019-06-05 Endo Global Ventures Clostridium histolyticum enzyme
US9636385B2 (en) 2012-10-24 2017-05-02 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
KR20240001279A (ko) 2017-03-28 2024-01-03 엔도 벤쳐즈 리미티드 개선된 콜라게나제 생성 방법
RU2745328C1 (ru) * 2020-05-24 2021-03-23 Федеральное государственное бюджетное учреждение «Федеральный центр травматологии, ортопедии и эндопротезирования» Министерства здравоохранения и социального развития РФ (г. Чебоксары) Способ лечения болевого синдрома при адгезивном капсулите

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
US5989888A (en) 1996-01-24 1999-11-23 Roche Diagnostics Corporation Purified mixture of collagenase I, collagenase II and two other proteases
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
US6060474A (en) 1998-11-05 2000-05-09 New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for preventing scar tissue formation
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
EP1433845A1 (en) 2002-12-23 2004-06-30 Georg-August-Universität Clostridium tetani collagenase and uses thereof
US7854929B2 (en) 2005-01-21 2010-12-21 The Research Foundation Of State University Of New York Method for treating lateral epicondylitis using collagenase
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite

Also Published As

Publication number Publication date
JP2008528498A (ja) 2008-07-31
HUE027236T2 (en) 2016-10-28
CA2593038A1 (en) 2006-07-27
AU2006206393A1 (en) 2006-07-27
CA2593038C (en) 2015-03-17
CY1120193T1 (el) 2018-12-12
EP2977058A1 (en) 2016-01-27
RS54265B1 (en) 2016-02-29
US20130330320A1 (en) 2013-12-12
HK1109592A1 (en) 2008-06-13
HRP20150889T1 (hr) 2015-11-20
KR100989267B1 (ko) 2010-10-20
US8323643B2 (en) 2012-12-04
CN101107006B (zh) 2013-09-11
BRPI0607280A2 (pt) 2009-08-25
EP1846022B1 (en) 2015-05-20
SI1846022T1 (sl) 2016-01-29
US20150174216A1 (en) 2015-06-25
EP1846022A4 (en) 2009-08-05
WO2006078870A2 (en) 2006-07-27
ME02344B (me) 2016-06-20
PL1846022T3 (pl) 2016-06-30
DK1846022T3 (en) 2015-08-24
KR20070116587A (ko) 2007-12-10
AU2006206393B2 (en) 2010-04-08
ES2548516T3 (es) 2015-10-19
US20160354450A1 (en) 2016-12-08
HK1115295A1 (en) 2008-11-28
CN101107006A (zh) 2008-01-16
WO2006078870A3 (en) 2006-09-14
JP4967081B2 (ja) 2012-07-04
HK1221143A1 (zh) 2017-05-26
NZ556160A (en) 2009-11-27
US20060204488A1 (en) 2006-09-14
PT1846022E (pt) 2015-09-03
US20090123454A1 (en) 2009-05-14
EP1846022A2 (en) 2007-10-24
KR20090130158A (ko) 2009-12-17

Similar Documents

Publication Publication Date Title
MX2007008764A (es) Metodos para tratar capsulitis adhesiva.
WO2007100675A3 (en) Collagenase for treating cellulite
MY162903A (en) Methods of treatment of pancreatic cancer
MX337511B (es) Medicamentos y metodos para tratar cefaleas.
UA99608C2 (en) PDGFRb-SPECIFIC INHIBITORS
EA201690745A1 (ru) Способы лечения и предотвращения болезни "трансплантат против хозяина"
IL206563A (en) A preparation or drug containing a suspension of blood cells that contain asparaginase for use in the treatment of pancreatic cancer
WO2011020061A3 (en) Compositions and methods of for treating bipolar disorder
TW200503751A (en) Methods for treating sinus headache
MX2010012860A (es) Metodos para tratar cancer del sistema nervioso central.
MX2019009227A (es) Métodos para tratar cáncer con inhibidores de hsp90.
TW200740804A (en) Glucokinase activators
NZ603717A (en) Suture line administration technique using botulinum toxins
MY150602A (en) Subtituted-quinoxaline-type piperidine compounds and the uses thereof
MX2007003795A (es) Oligoribonucleotidos y metodos de uso de los mismos para tratamiento de la alopecia, insuficiencia renal aguda y otras enfermedades.
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
MX2009002893A (es) Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
HK1140141A1 (en) Combination therapies comprising a quinoxaline inhibitors of pi3k-alpha for use in the treatment of cancer
UA103614C2 (uk) Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки
MX2019007779A (es) Metodo cosmetico para el tratamiento o reduccion de paniculopatia edemato-fibroesclerotica (pefe).
WO2007100590A3 (en) Methods for treating cellulite
RU2013132566A (ru) Терапевтическое средство от грыжи межпозвоночного диска
MX2009000359A (es) Metodos paratratar y limitar trastornos fibroticos y queloides.
AU2009246603A8 (en) Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction
WO2009016488A3 (en) Compositions comprising tetracyclic antidepressants for treatment of cancer and related methods

Legal Events

Date Code Title Description
FG Grant or registration